Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2013 (2013), Article ID 692071, 13 pages
http://dx.doi.org/10.1155/2013/692071
Review Article

Role of the Plasma Membrane Transporter of Organic Cations OCT1 and Its Genetic Variants in Modern Liver Pharmacology

1Laboratory of Experimental Hepatology and Drug Targeting (HEVEFARM), Biomedical Research Institute of Salamanca (IBSAL), University of Salamanca, Campus Miguel de Unamuno, E.D. S-09, 37007 Salamanca, Spain
2Department of Physiology and Pharmacology, University of Salamanca, Campus Miguel de Unamuno, E.D. S-09, 37007 Salamanca, Spain
3National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Instituto de Salud Carlos III, Sinesio Delgado 4, 28029 Madrid, Spain

Received 30 April 2013; Accepted 4 July 2013

Academic Editor: Hongqun Liu

Copyright © 2013 Elisa Lozano et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [15 citations]

The following is the list of published articles that have cited the current article.

  • Miriam Marlene Medina-Enríquez, Verónica Alcántara-Farfán, Leopoldo Aguilar-Faisal, José Guadalupe Trujillo-Ferrara, Lorena Rodríguez-Páez, and Alba Laura Vargas-Ramírez, “ N- ω -chloroacetyl- l -ornithine, a new competitive inhibitor of ornithine decarboxylase, induces selective growth inhibition and cytotoxicity on human cancer cells versus normal cells ,” Journal of Enzyme Inhibition and Medicinal Chemistry, pp. 1–9, 2014. View at Publisher · View at Google Scholar
  • David M. Klein, Stephen H. Wright, and Nathan J. Cherrington, “Xenobiotic Transporter Expression along the Male Genital Tract1,” Reproductive Toxicology, 2014. View at Publisher · View at Google Scholar
  • Mihaela Aldea, Lucian Craciun, Ciprian Tomuleasa, Ioana Berindan-Neagoe, Gabriel Kacso, Ioan Stefan Florian, and Carmen Crivii, “Repositioning metformin in cancer: genetics, drug targets, and new ways of delivery,” Tumor Biology, 2014. View at Publisher · View at Google Scholar
  • Jasna Klen, Katja Goričar, Andrej Janež, and Vita Dolžan, “The Role of Genetic Factors and Kidney and Liver Function in Glycemic Control in Type 2 Diabetes Patients on Long-Term Metformin and Sulphonylurea Cotreatment,” BioMed Research International, vol. 2014, pp. 1–7, 2014. View at Publisher · View at Google Scholar
  • Shaojun Shi, and Yunqiao Li, “Interplay of drug-metabolizing enzymes and transporters in drug absorption and disposition,” Current Drug Metabolism, vol. 15, no. 10, pp. 915–941, 2015. View at Publisher · View at Google Scholar
  • Philip M. E. Probert, Stephanie K. Meyer, Fouzeyyah Alsaeedi, Andrew A. Axon, Emma A. Fairhall, Karen Wallace, Michelle Charles, Fiona Oakley, Paul A. Jowsey, Peter G. Blain, and Matthew C. Wright, “An expandable donor-free supply of functional hepatocytes for toxicology,” Toxicol. Res., vol. 4, no. 2, pp. 203–222, 2015. View at Publisher · View at Google Scholar
  • M A Daniels, C Kan, D M Willmes, K Ismail, F Pistrosch, D Hopkins, G Mingrone, S R Bornstein, and A L Birkenfeld, “Pharmacogenomics in type 2 diabetes: oral antidiabetic drugs,” The Pharmacogenomics Journal, 2016. View at Publisher · View at Google Scholar
  • Lucie Hyrsova, Tomas Smutny, Frantisek Trejtnar, and Petr Pavek, “Expression of organic cation transporter 1 (OCT1): unique patterns of indirect regulation by nuclear receptors and hepatospecific gene regulation,” Drug Metabolism Reviews, pp. 1–20, 2016. View at Publisher · View at Google Scholar
  • Anabel García-Heredia, Marta Riera-Borrull, Isabel Fort-Gallifa, Fedra Luciano-Mateo, Noemí Cabré, Anna Hernández-Aguilera, Jorge Joven, and Jordi Camps, “Metformin administration induces hepatotoxic effects in paraoxonase-1-deficient mice,” Chemico-Biological Interactions, 2016. View at Publisher · View at Google Scholar
  • Daniel Grimm, Jonas Lieb, Veronika Weyer, Johanna Vollmar, Felix Darstein, Anja Lautem, Maria Hoppe-Lotichius, Sandra Koch, Arno Schad, Jörn M. Schattenberg, Marcus A. Wörns, Arndt Weinmann, Peter R. Galle, and Tim Zimmermann, “Organic Cation Transporter 1 (OCT1) mRNA expression in hepatocellular carcinoma as a biomarker for sorafenib treatment,” BMC Cancer, vol. 16, no. 1, 2016. View at Publisher · View at Google Scholar
  • Hye In Kim, Johannes Raffler, Wenyun Lu, Jung-Jin Lee, Deepti Abbey, Danish Saleheen, Joshua D. Rabinowitz, Michael J. Bennett, Nicholas J. Hand, Christopher Brown, and Daniel J. Rader, “Fine Mapping and Functional Analysis Reveal a Role of SLC22A1 in Acylcarnitine Transport,” The American Journal of Human Genetics, 2017. View at Publisher · View at Google Scholar
  • Shoeb Ikhlas, and Masood Ahmad, “Metformin: Insights into its anticancer potential with special reference to AMPK dependent and independent pathways,” Life Sciences, 2017. View at Publisher · View at Google Scholar
  • Obinna N. Obianom, Ana L. Coutinho, Wei Yang, Hong Yang, Fengtian Xue, and Yan Shu, “Incorporation of a Biguanide Scaffold Enhances Drug Uptake by Organic Cation Transporters 1 and 2,” Molecular Pharmaceutics, 2017. View at Publisher · View at Google Scholar
  • Jose J.G. Marin, Elisa Lozano, Elisa Herraez, Maitane Asensio, Silvia Di Giacomo, Marta R. Romero, Oscar Briz, Maria A. Serrano, Thomas Efferth, and Rocio I.R. Macias, “Chemoresistance and chemosensitization in cholangiocarcinoma,” Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2017. View at Publisher · View at Google Scholar
  • Rocio I.R. Macias, Dominik Bettinger, Heike Bantel, Daniel Jahn, Jose J.G. Marin, Andreas Geier, Johannes Weiss, and Ruba Al-Abdulla, “The lack of the organic cation transporter OCT1 at the plasma membrane of tumor cells precludes a positive response to sorafenib in patients with hepatocellular carcinoma,” Oncotarget, vol. 8, no. 9, pp. 15846–15857, 2017. View at Publisher · View at Google Scholar